Picture of Cohance Lifesciences logo

COHANCE — Cohance Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Suven Pharmaceuticals March Quarter Consol Profit Falls

June 18 (Reuters) - Suven Pharmaceuticals Ltd  SUVH.NS :
    * SUVEN PHARMACEUTICALS - MARCH QUARTER CONSOL NET PROFIT
741.8
MILLION RUPEES VERSUS 748.2 MILLION RUPEES
    * SUVEN PHARMACEUTICALS  - MARCH QUARTER CONSOL REVENUE FROM
OPERATIONS 1.85 BILLION RUPEES VERSUS 2.51 BILLION RUPEES

Source text for Eikon:  ID:nBSE58cYKr 
Further company coverage:  SUVH.NS 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Cohance Lifesciences

See all news